Medico Remedies (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
Medico Remedies Limited |
|||
Price: ₹74.25 (-0.23%) | |||
52 Week Low: ₹34.80 52 Week High: ₹90.00 |
|||
Market Capital: 379.31 Crore (Smallcap) | |||
Healthcare -> Drug Manufacturers - Specialty & Generic |
Show Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Medico Remedies Share Price Target For 2025
- 1.1.1: Medico Remedies Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Medico Remedies Share Price Target For 2026
- 1.2.1: Medico Remedies Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Medico Remedies Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Medico Remedies Brief Company Overview
- 4: Medico Remedies Financial Performance
- 4.0.1: Is Medico Remedies A Good Buy For Long Term?
Medico Remedies, a Small Cap company in the Drug Manufacturers - Specialty & Generic Industry has delivered 1217.8% returns in 5-year with 5.9% profit margin, making it a potential Multibagger.
To predict the Medico Remedies's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Medico Remedies Share Price Target For 2025
The line chart displays the monthly closing prices of Medico Remedies with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medico Remedies shares in 2025, see the table below.
Medico Remedies Share Price Target Table For 2025
Level | Value | Analysis |
---|---|---|
2025 Target 3 | 84.25 (+13.46%) | Price Action: 07 Feb 2024 High |
2025 Target 2 | 83.4 (+12.32%) | Price Action: 05 Jan 2024 Low |
2025 Target 1 | 82.55 (+11.17%) | Price Action: 13 Feb 2024 High |
Current Price | 74.25 | Medico Remedies's share price as of 31 Jan 2025 |
Stop Loss 1 | 70.0 (-5.73%) | Price Action: 20 Mar 2024 Low |
Stop Loss 2 | 68.91 (-7.2%) | Fibonacci Retracement Level 38.20% |
Stop Loss 3 | 68.03 (-8.38%) | Price Action: 20 Jan 2025 High |
Short-Term Technical Outlook
Current Technical Position: Medico Remedies is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹64.57 serves as the nearest technical reference point.
Historical Returns: 3-month: +28.62% | 6-month: +93.56% | 1-year: -9.94%
Medico Remedies Share Price Target For 2026
The line chart displays the monthly closing prices of Medico Remedies with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medico Remedies shares in 2026, see the table below.
Medico Remedies Share Price Target Table For 2026
Level | Value | Analysis |
---|---|---|
2026 Target 3 | 119.64 (+61.13%) | Price Action: Chart |
2026 Target 2 | 117.41 (+58.12%) | Price Action: Chart |
2026 Target 1 | 116.25 (+56.56%) | Fibonacci Extension Level 123.60% |
Current Price | 74.25 | Medico Remedies's share price as of 31 Jan 2025 |
Stop Loss 1 | 64.33 (-13.37%) | Price Action: 20 Jan 2025 Low |
Stop Loss 2 | 63.6 (-14.35%) | Price Action: 16 Jan 2025 High |
Stop Loss 3 | 62.9 (-15.29%) | Price Action: 14 Jan 2025 High |
Long-Term Technical Outlook
52-Week Range Analysis: Medico Remedies is currently trading at 71.5% of its 52-week range (₹34.8 - ₹90).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: -9.94% | 3-year: +358.33% | 5-year: +1,217.75%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Medico Remedies Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
Year | Target 1 | Target 1 YoY Chg % | Target 2 |
---|---|---|---|
Current Price | ₹74.25 | ||
2025 | ₹79.30 | +6.8% | ₹80.49 |
2026 | ₹115.48 | +45.62% | ₹117.21 |
2027 | ₹149.50 | +29.45% | ₹151.74 |
2028 | ₹213.97 | +43.12% | ₹217.18 |
2029 | ₹273.53 | +27.83% | ₹277.63 |
2030 | ₹329.90 | +20.6% | ₹334.85 |
2031 | ₹407.96 | +23.66% | ₹414.08 |
2032 | ₹538.15 | +31.91% | ₹546.22 |
2033 | ₹697.63 | +29.63% | ₹708.09 |
2034 | ₹868.39 | +24.47% | ₹881.42 |
2035 | ₹1,051.01 | +21.02% | ₹1,066.78 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Medico Remedies Brief Company Overview
Medico Remedies Limited: A Comprehensive Overview Established in 1994, Medico Remedies Limited is an esteemed Indian pharmaceutical company known for its diverse product range and commitment to healthcare excellence. Key Products: Antibiotics, anti-infectives,...
vitamins, cardiovascular products, antidepressants, antimalarials, syrups, ointments, anti-diabetics, etc. Market Presence: Established in Mumbai, India, with extensive exports globally. Medico Remedies Limited is widely recognized for its high-quality formulations and unwavering commitment to patient well-being.Medico Remedies Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 379.31 Crore | Market valuation of Medico Remedies's shares. |
Revenue (TTM) | 144.24 Crore | Total revenue generated by Medico Remedies over the past twelve months. |
Net Income (TTM) | +8.54 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | +6.68% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | +5.92% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) |
-2.1% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) |
+19.6% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio |
15.37 | Company's total debt divided by total shareholder equity. |
Total Debt | 8.05 Crore | Sum of Medico Remedies's current & long-term financial obligations. |
Total Cash | 1.54 Crore | Total amount of liquid funds available to Medico Remedies. |
Beta | 0.15 | Beta is less than 1 indicating that the Medico Remedies's price is less volatile than the market. |
Is Medico Remedies A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.